ArticleArchives of gerontology and geriatrics2026
Associations of serum neurofilament light chain concentration with able life and healthy life in older adults: The Cardiovascular Health Study.
Article in Archives of gerontology and geriatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
backgroundSerum neurofilament light chain (NfL) is a biomarker of brain injury. We examined the associations of serum NfL concentration with able life and healthy life among older adults.
methodsWe analyzed Cardiovascular Health Study participants with measured NfL and no history of stroke or transient ischemic attack (TIA). Over 13 years' follow-up, outcomes were years of life (YOL), years of able life (YAL), years of healthy life (YHL), and proportion of follow-up spent able (YAL/YOL%) or healthy (YHL/YOL%). "Able" was defined by independence in all activities of daily living, and "healthy" was defined by self-reported health status. Linear regression and linear spline regression models were used to estimate the difference in each outcome associated with a 50% increment in serum NfL, an increment within the range of the observed data.
resultsAmong 1957 participants (mean age 77.8; 61% female), in the adjusted linear model, each 50% increment in NfL was associated with 0.6 fewer YOL (95% CI: -0.7, -0.4), 0.7 fewer YAL (-0.8, -0.5), 0.5 fewer YHL (-0.7, -0.4), 2.9% lower YAL/YOL% (-4.0%, -1.7%) and 1.8% lower YHL/YOL% (-3.1%, -0.6%). Spline analysis showed the strongest associations at NfL of 19.7-33.9 pg/mL, where each 50% increment in NfL was associated with 6.5% lower YAL/YOL% (-9.4%, -3.6%) and 5.6% lower YHL/YOL% (-8.8%, -2.4%).
conclusionsHigher serum NfL concentration was associated with less able and healthy life among older adults free of stroke or TIA. Further investigation of NfL, including longitudinal evaluation, is needed to understand its relationship with functional status.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.